HIMS

Hims & Hers Health
D

HIMS

23.725
USD
-0.29
(-1.19%)
Market Closed
Volume
407,212
EPS
-0
Div Yield
-
P/E
-263
Market Cap
5,491,333,814
OverviewNews
Related Instruments
AMZN
AMZN
266.32 USD
-2.04
(-0.76%)
COST
COST
1,027.82 USD
-22.30
(-2.12%)
CVS
CVS
93.243 USD
-0.117
(-0.13%)
TGT
TGT
125.595 USD
-0.575
(-0.46%)
WMT
WMT
120.280 USD
-1.060
(-0.87%)
More
News
ArincenArincen
BTCUSD
OILUSD
BNTUSD
XAUUSD
NVDA
INTC
MU
QCOM
1 week ago

US Inflation Pressures Wall Street as Oil Surge Deepens Market Anxiety

ArincenArincen
AAPL
ORCL
MSFT
NVDA
AMZN
XAUUSD
XAGUSD
EURUSDEURUSD
3 months ago

Market Roundup: What Happened Yesterday and What Awaits Us Today (February 10)

More

Title: Hims & Hers Health

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.